Clinical Guides
Approach to Jaundice
A physiology-led and emergency-aware approach to jaundice that distinguishes bilirubin fractions and liver-injury patterns, identifies acute liver failure, cholangitis and haemolysis, and adapts investigation and referral to Indian infectious, drug-exposure and access realities.
MedNext Academy | 14 min read
Approach to Jaundice
A physiology-led and emergency-aware approach to jaundice that distinguishes bilirubin fractions and liver-injury patterns, identifies acute liver failure, cholangitis and haemolysis, and adapts investigation and referral to Indian infectious, drug-exposure and access realities.
Summary
Jaundice is visible yellow discolouration caused by bilirubin accumulation, but the bedside label does not identify the mechanism. The safest approach begins with physiology: decide whether bilirubin is predominantly unconjugated or conjugated, then determine whether accompanying liver chemistry is hepatocellular, cholestatic or mixed. Unconjugated hyperbilirubinaemia suggests increased production, impaired hepatic uptake or impaired conjugation. Conjugated bilirubin is water soluble and usually reflects impaired hepatocellular excretion or obstruction; it can darken urine. A hepatocellular pattern has aminotransferase elevation out of proportion to alkaline phosphatase, whereas a cholestatic pattern has alkaline phosphatase elevation out of proportion to aminotransferases. Mixed injury lies between them.
The first clinical question is not the precise diagnosis but whether delay is dangerous. Confusion, asterixis, hypoglycaemia, bleeding, rising INR, acidosis or haemodynamic deterioration may indicate acute liver failure or decompensation. Fever, right-upper-quadrant pain, jaundice, hypotension or altered mentation raises concern for acute cholangitis and urgent biliary drainage. Severe anaemia or intravascular haemolysis can also destabilise rapidly. Pregnancy, infancy and immunosuppression require modified differentials and lower escalation thresholds.
Assessment combines medication and exposure chronology, infection risk, examination, fractionated bilirubin, liver chemistries, INR, albumin, blood count and targeted imaging. Ultrasound is usually the initial structural test for conjugated or cholestatic jaundice; cross-sectional imaging and MRCP or ERCP answer selected downstream questions. This draft supports clinical reasoning and early escalation, not unsupervised treatment, and remains quarantined following MedNext Clinical Team review.
How Common Is It?
Jaundice is a presentation rather than one disease, so a single prevalence estimate is misleading. Transient neonatal jaundice, Gilbert syndrome, gallstone obstruction, viral hepatitis, alcohol-related disease, drug-induced liver injury, cirrhosis and malignancy occur in different populations and settings. Visible jaundice usually appears only after bilirubin has risen substantially, meaning laboratory hyperbilirubinaemia is more common than obvious yellowing. Case mix also differs between community clinics, obstetric services, emergency departments, surgical units and tertiary hepatology centres.
Viral hepatitis remains a major global and Indian health burden. WHO reporting shows that hepatitis B and C account for most viral-hepatitis mortality, yet testing and treatment coverage remain incomplete in many low- and middle-income settings. Hepatitis A and E remain important acute causes where sanitation and water safety are limited; hepatitis E is particularly consequential in pregnancy. India also carries substantial gallstone, metabolic liver disease, alcohol-related disease and tuberculosis burdens. Antituberculous medicines, antimicrobials, antiepileptics and multi-ingredient herbal or traditional products contribute to drug-induced injury.
Frequency never determines urgency. Acute liver failure is uncommon but lethal without rapid specialist care; ascending cholangitis can progress quickly to septic shock; pancreatic or biliary malignancy may initially cause painless obstruction; and haemolysis can produce mainly unconjugated bilirubin before jaundice is dramatic. Published estimates are limited by referral bias, inconsistent bilirubin thresholds, incomplete viral testing and under-recorded non-prescription exposures. Services should audit aetiology, time to ultrasound, time to drainage, acute-liver-failure transfer, diagnostic completeness and follow-up rather than presenting one national jaundice percentage as universally applicable.
Risk Factors
Risk assessment should follow the bilirubin pathway. Unconjugated jaundice is more likely with haemolysis, ineffective erythropoiesis, a large haematoma, transfusion reaction or inherited conjugation disorders such as Gilbert syndrome. Ask about G6PD deficiency, haemoglobinopathy, recent transfusion, oxidant medicines, malaria exposure, mechanical heart valves and autoimmune disease. In newborns, prematurity, bruising, feeding difficulty, blood-group incompatibility, infection and enzyme disorders alter risk and require age-specific pathways rather than this adult framework.
Hepatocellular injury risk includes hepatitis exposure, alcohol, obesity and diabetes, ischaemia, autoimmune disease and medicines. Establish all prescribed, over-the-counter, gym, herbal and traditional products with start dates, dose changes and stop dates. High-risk histories include paracetamol overdose, antituberculous therapy, antimicrobials, anticonvulsants and recent anaesthesia or hypotension. Viral risks include unsafe injections, unscreened blood exposure, dialysis, sexual exposure, perinatal transmission, travel, unsafe food or water and close contacts. Autoimmune disease and pregnancy broaden the differential.
Cholestatic or obstructive risk rises with gallstones, previous biliary surgery, pancreatitis, primary sclerosing cholangitis, inflammatory bowel disease, strictures, parasites and pancreatic, biliary or hepatic malignancy. Older age, weight loss and progressive painless jaundice are concerning for cancer, while pain and fever suggest infection or stones but are not universal. Immunosuppression increases opportunistic infection and can blunt fever. Indian practice must also consider leptospirosis, severe malaria, dengue-associated hepatic injury, sepsis, liver abscess and abdominal or hepatobiliary tuberculosis in the right context. Epidemiology changes probability; it must not become a substitute for biochemical classification, imaging or tissue and microbiological confirmation.
Diagnosis
History
Define onset, progression, pain, fever, pruritus, dark urine, pale stool, weight loss, anorexia, vomiting, confusion, bleeding and sleep reversal. Ask about prior jaundice, gallstones, liver disease, transfusion, surgery, pregnancy, alcohol and every medication or supplement. Record travel, water and food exposure, needles, tattoos, sexual and household exposure, tuberculosis contact, occupation, animal contact and recent shock. A careful drug timeline is more informative than asking only about current prescriptions.
Examination
Perform ABCDE first, including glucose, mental state and perfusion. Confirm jaundice in sclerae under good light, then assess fever, hydration, pallor, bruising, scratch marks, oedema, lymphadenopathy and weight loss. Examine for right-upper-quadrant tenderness, guarding, hepatomegaly, splenomegaly, ascites and a palpable gallbladder. Look for chronic liver disease, asterixis and encephalopathy. Examine heart and lungs for congestion or infection. In haemolysis, seek pallor, splenomegaly and haemoglobinuria; absence of classic signs does not exclude it.
Investigations
Repeat and fractionate bilirubin when results and clinical state permit. Order ALT, AST, alkaline phosphatase, GGT, albumin and INR, recognizing that albumin and INR relate more closely to synthesis than aminotransferases do. Add blood count, reticulocytes, film, LDH, haptoglobin and direct antiglobulin testing when haemolysis is plausible. Check glucose, renal function, electrolytes, lactate and paracetamol concentration in acute severe illness; select viral serology or nucleic-acid testing, autoimmune markers and cultures from the pattern. Ultrasound evaluates duct dilatation, gallstones, liver morphology, portal flow and masses. CT, MRCP, endoscopic ultrasound or ERCP is chosen for a defined question; ERCP is principally therapeutic when obstruction or cholangitis requires intervention.
Differential Diagnosis
Predominantly unconjugated hyperbilirubinaemia is caused by bilirubin overproduction or limited uptake and conjugation. Haemolysis may be immune, microangiopathic, infective, mechanical, oxidant-related or inherited. Ineffective erythropoiesis and resorbing haematoma also increase bilirubin load. Gilbert syndrome produces intermittent mild unconjugated elevation, often during fasting, illness or stress, with otherwise reassuring liver chemistry; it should not be invoked when anaemia, marked elevation or systemic illness is unexplained. Crigler-Najjar syndromes are rare and usually present earlier. Because unconjugated bilirubin is not water soluble, isolated bilirubinuria points away from a purely unconjugated process.
Conjugated hyperbilirubinaemia may be hepatocellular, cholestatic or mixed. Hepatocellular causes include hepatitis A, B, C or E, drug-induced injury, alcohol-associated hepatitis, autoimmune hepatitis, ischaemic hepatitis, Wilson disease and severe systemic infection. Pregnancy-specific disease includes intrahepatic cholestasis, hyperemesis-associated injury, pre-eclampsia or HELLP and acute fatty liver of pregnancy; gestation and clinical syndrome guide urgency. Congestive hepatopathy and infiltrative disease can create mixed patterns.
Extrahepatic cholestasis includes common-duct stones, acute cholangitis, benign postoperative or inflammatory strictures, pancreatitis and pancreatic, ampullary or cholangiocarcinoma. Intrahepatic cholestasis includes drug injury, sepsis, primary biliary cholangitis and primary sclerosing cholangitis. Indian infectious differentials include leptospirosis, malaria, dengue, amoebic or pyogenic liver abscess and tuberculosis, but confirmation is essential because empirical antituberculous treatment can itself cause severe liver injury. Rare mimics include carotenaemia, which spares sclerae and does not raise bilirubin, and laboratory interference. More than one cause can coexist, especially gallstones with sepsis, chronic liver disease with acute viral or drug injury, or haemolysis with hepatic dysfunction.
Management
Management starts with severity, not a bilirubin target. Resuscitate airway, breathing and circulation; monitor glucose, urine output, cognition and coagulation; stop non-essential potentially hepatotoxic products; and involve senior clinicians early. Suspected acute liver failure requires urgent hepatology and transplant-centre discussion, not observation for a second set of routine tests. Protect the airway when encephalopathy advances, correct hypoglycaemia, investigate the cause rapidly and avoid fluid, sedative and procedure-related harms. Suspected paracetamol toxicity warrants immediate local toxicology or acute-liver-failure protocol treatment without waiting for clinical jaundice.
Acute cholangitis needs sepsis care, blood cultures where they do not delay therapy, prompt antibiotics based on local resistance and renal function, and urgent source control through biliary drainage. Classic Charcot features are insufficiently sensitive; shock or altered mentation indicates severe disease. Stable obstruction without infection still needs timely imaging and gastroenterology or surgical planning. ERCP should be used when therapeutic benefit is expected, not as a low-risk diagnostic substitute for MRCP or other imaging. Haemolysis management is cause-specific and may require transfusion support, stopping an oxidant trigger, infection treatment or haematology input.
Viral hepatitis management depends on virus, severity, chronicity, pregnancy and comorbidity; testing, counselling, contact measures and specialist antiviral decisions should follow national pathways. Drug-induced injury requires stopping the likely agent when safe, documenting chronology, excluding alternatives and reporting serious reactions. Pruritus, nutrition, alcohol withdrawal risk and complications of chronic liver disease need active care. Do not treat a laboratory number with unproven liver tonics or empirical steroids. Discharge is appropriate only when dangerous causes are excluded or controlled, physiology and cognition are stable, follow-up is reliable and the patient receives explicit return advice for confusion, bleeding, fever, worsening pain, vomiting or reduced urine.
Prescribing Information
Prescribing in jaundice starts with the diagnosis, hepatic reserve, renal function, bleeding risk, pregnancy status and complete medicine exposure—not a bilirubin value alone. In possible drug-induced liver injury, AASLD directs a detailed prescription, non-prescription, herbal and dietary-supplement history, including start and stop dates, dose changes, prior exposure and the course after withdrawal. Stop a suspected non-essential causative agent when it is safe to do so, exclude competing causes and avoid deliberate re-exposure except when the anticipated benefit is high in a serious or life-threatening condition. Use current Indian product information and specialist advice for all hepatic dose adjustments, contraindications and interactions.
Suspected paracetamol overdose or staggered excess is an emergency: start the local toxicology or acute-liver-failure pathway without waiting for jaundice. For suspected cholangitis, obtain cultures where this does not delay treatment, select empiric antibiotics to local resistance and the person's allergy and renal function, and narrow treatment when cultures and source control clarify the diagnosis. Antimicrobials do not relieve mechanical obstruction; biliary drainage is a specialist source-control decision.
Do not use corticosteroids, antiviral treatment, antituberculous therapy, pruritus medicines or blood products as a generic response to jaundice. Each requires a confirmed or strongly supported indication and an agent-specific risk review. In pregnancy, check current agent-specific evidence with obstetric medicine. Encephalopathy and acute liver failure require specialist-led medicine review, including sedatives and opioids. Counselling should cover alcohol avoidance, medicine reconciliation and urgent return for confusion, bleeding, fever, worsening pain, vomiting or reduced urine; dietary restriction alone does not treat the cause.
When to Refer
Refer immediately for suspected acute liver failure: new encephalopathy with coagulopathy in a person without established cirrhosis, rapidly rising INR, recurrent hypoglycaemia, acidosis, renal injury or clinical deterioration. Contact a transplant-capable hepatology centre early because transfer becomes less safe after cerebral oedema, shock or multiorgan failure develops. Acute-on-chronic liver failure, variceal bleeding, tense ascites with infection concern, severe alcohol withdrawal or unexplained decompensation also needs urgent specialist and critical-care assessment.
Fever or sepsis with jaundice, duct dilatation, right-upper-quadrant pain or suspected obstruction requires urgent gastroenterology, surgery or interventional radiology input for source control. Painless progressive jaundice, weight loss, a mass, new duct dilatation or unexplained cholestasis requires expedited hepatopancreatobiliary cancer assessment. Significant haemolysis, falling haemoglobin, thrombocytopenia, schistocytes or transfusion reaction needs urgent haematology or transfusion-medicine support. Pregnant patients with jaundice, pruritus plus abnormal tests, hypertension, thrombocytopenia, hypoglycaemia or systemic illness require same-day obstetric and medical assessment.
Transfer decisions should be capability-based. A facility without round-the-clock ultrasound, cross-sectional imaging, ERCP, blood bank, critical care or specialist hepatology should identify the accepting team while resuscitation and initial tests proceed. Send medication timelines, trends rather than single results, coagulation, glucose, renal function, viral and pregnancy results, images and cultures. Outpatient referral is appropriate for stable persistent abnormalities, chronic viral hepatitis, suspected autoimmune or metabolic disease and unexplained isolated bilirubin elevation after haemolysis is assessed. Normal imaging does not end referral when biochemistry remains concerning, and normal aminotransferases do not reassure against obstruction, synthetic failure or some infiltrative disease.
Red Flags
Red flags for acute liver failure are altered behaviour, sleep reversal, confusion, asterixis, somnolence, seizures, hypoglycaemia, increasing INR, metabolic acidosis, renal injury, rising lactate or haemodynamic instability. Jaundice with encephalopathy is never a routine outpatient problem. A falling aminotransferase concentration is not necessarily improvement if functioning liver mass is being lost while INR and bilirubin worsen. Significant bleeding, rapidly increasing abdominal distension, fever in ascites or reduced urine output also demands emergency evaluation.
Red flags for biliary sepsis or obstruction include fever or rigors, right-upper-quadrant pain, hypotension, altered mentation, persistent vomiting, tender hepatomegaly and imaging evidence of duct dilatation or an obstructing lesion. The full Charcot triad is not required. Painless progressive jaundice with pale stool, pruritus, weight loss or a palpable non-tender gallbladder suggests malignancy until properly investigated. Severe epigastric pain radiating to the back may indicate pancreatitis or an impacted stone.
Haematological warnings include syncope, dyspnoea, chest pain, severe pallor, haemoglobinuria, rapidly falling haemoglobin, thrombocytopenia, schistocytes, recent transfusion or malaria risk. Pregnancy-related warnings include vomiting with dehydration early in gestation, hypertension, headache, right-upper-quadrant pain, bleeding, reduced fetal movement, thrombocytopenia, hypoglycaemia or late-pregnancy systemic illness. Drug and infection red flags include intentional or staggered paracetamol excess, antituberculous-drug exposure with symptoms, severe rash or mucosal disease, shock, travel-related fever and immunosuppression. Social red flags include inability to obtain urgent imaging, unsafe discharge, unclear medicines or delayed transfer; access barriers are clinical risks and should be documented and escalated.
Indian Clinical Context
Indian clinicians encounter jaundice across heterogeneous systems, from primary centres with limited fractionated bilirubin testing to tertiary units offering MRCP, ERCP and transplant care. A safe pathway maps actual capability by time of day. Bedside glucose, INR, blood count, renal profile, pregnancy testing and ultrasound often provide high-value early discrimination, but lack of an advanced test must trigger referral when acute liver failure, cholangitis or malignancy is plausible. Serial transfers between facilities without ownership waste the clinical window; obtain named acceptance, send images digitally and continue resuscitation during transport planning.
Infectious context matters. Hepatitis A and E can follow contaminated water or food, while chronic hepatitis B and C require linkage to confirmatory testing and treatment rather than stigma. Malaria, leptospirosis, dengue, sepsis and liver abscess can include jaundice. Tuberculosis can involve liver, nodes or biliary structures, but empirical treatment without a defensible diagnosis risks delayed cancer or obstruction and drug-induced liver injury. Antituberculous hepatotoxicity requires coordination with the TB programme and appropriate alternative regimens, not unsupervised cessation of all care. Ask explicitly about traditional medicines, bodybuilding products and medicines bought without prescription; non-disclosure often reflects assumptions, not intent.
Cost-sensitive practice should avoid both indiscriminate panels and false economy. Fractionation and pattern classification should precede repeated unstructured testing. Ultrasound is an excellent first structural study but can miss early obstruction or distal lesions; persistent clinical and biochemical concern may require MRCP, CT, endoscopic ultrasound or referral. Use qualified interpretation and communicate uncertainty in the patient’s language. Viral-hepatitis counselling should protect confidentiality and explain household, sexual, injection and perinatal prevention without moral judgement. Document dates, product names and batches for suspected drug injury, report serious reactions, and ensure follow-up after apparent symptom improvement because biochemical recovery may lag or deterioration may be silent.
NMC Competency Mapping
This guide integrates competencies across internal medicine, surgery, paediatrics, obstetrics-gynaecology, pathology, microbiology, pharmacology and emergency care. The learner should elicit a structured jaundice, exposure and medication history; distinguish conjugated from unconjugated bilirubin; classify hepatocellular, cholestatic and mixed patterns; examine for chronic liver disease, obstruction, haemolysis and encephalopathy; and construct a threat-prioritized differential. Learners should justify fractionated bilirubin, liver chemistries, INR, haemolysis testing, viral tests and first-line ultrasound rather than ordering a memorized panel.
Case-based assessment should include a febrile patient with duct obstruction, a person taking antituberculous medicines, a pregnant patient with vomiting or late-gestation systemic illness, an anaemic patient with unconjugated bilirubin, and an apparently improving patient whose aminotransferases fall while INR worsens. Candidates should explain why urine bilirubin implies conjugated bilirubin, why alkaline phosphatase needs hepatic confirmation, why ERCP is usually therapeutic, and why acute liver failure is defined by physiology and synthesis rather than bilirubin magnitude. Communication competencies include overdose enquiry without judgement, viral-hepatitis confidentiality, pregnancy-sensitive counselling and structured transfer.
Competence has boundaries. Undergraduate knowledge does not authorize independent ERCP, liver biopsy, transplant listing, management of cerebral oedema, complex antiviral selection, antituberculous-regimen redesign or steroid treatment for presumed autoimmune hepatitis. These require supervision, institutional protocols and assessed procedural skills. Faculties should verify exact wording against the current NMC curriculum rather than fabricating a single code for a cross-disciplinary presentation. The safe graduate outcome is accurate initial classification, recognition of time-critical syndromes, rational first tests, avoidance of harmful empiricism and early referral with a usable clinical handover.
Key Exam Pearls for NEET PG
Unconjugated bilirubin reflects overproduction, impaired uptake or conjugation and is not excreted in urine; conjugated bilirubin is water soluble, so bilirubinuria and dark urine support a conjugated component. Pale stool suggests reduced bile pigment reaching the gut. Gilbert syndrome causes intermittent mild unconjugated hyperbilirubinaemia with otherwise reassuring tests, commonly triggered by fasting or illness. Haemolysis is supported by anaemia, reticulocytosis, increased LDH, reduced haptoglobin and the blood-film or antiglobulin findings appropriate to cause.
Classify liver chemistry before reciting diseases. Hepatocellular injury means aminotransferases predominate; cholestasis means alkaline phosphatase predominates; mixed injury has both. GGT or another hepatic clue can support the source of alkaline phosphatase. Aminotransferases mark injury, not liver function. INR, glucose, mental state and clinical trajectory are crucial in acute failure; albumin changes more slowly. Acute liver failure is new coagulopathy with encephalopathy without pre-existing cirrhosis and demands early transplant-centre discussion.
Fever, jaundice and right-upper-quadrant pain suggest cholangitis, while hypotension and altered mentation indicate severe disease, but incomplete classic combinations do not exclude it. Ultrasound is usually first-line for structural cholestasis; MRCP delineates ducts non-invasively, whereas ERCP is generally used for drainage or other therapy. Painless progressive obstruction suggests malignancy. In India, actively consider viral hepatitis, antituberculous and traditional-product injury, leptospirosis, malaria and sepsis while still excluding stones and cancer. In pregnancy, think beyond viral hepatitis to intrahepatic cholestasis, HELLP and acute fatty liver. Never equate a falling AST or ALT with recovery when INR, bilirubin, glucose or cognition deteriorates.
Frequently Asked Questions
Does dark urine distinguish conjugated from unconjugated jaundice?
Dark urine caused by bilirubin supports a conjugated component because conjugated bilirubin is water soluble and can be filtered by the kidney. Pure unconjugated bilirubin is albumin bound and is not excreted in urine. However, dark urine can also reflect dehydration, blood, haemoglobin or myoglobin, so urinalysis and fractionated serum bilirubin are needed rather than relying on colour alone.
Can normal or falling aminotransferases exclude severe liver failure?
No. Aminotransferases indicate hepatocyte injury rather than functional reserve. In extensive necrosis they may fall because fewer viable cells remain, while INR, bilirubin, glucose, lactate, renal function and encephalopathy worsen. New confusion with coagulopathy, hypoglycaemia or clinical deterioration requires immediate acute-liver-failure assessment and early hepatology or transplant-centre discussion regardless of the AST or ALT direction.
When does jaundice need emergency biliary drainage?
Suspected acute cholangitis with obstruction requires urgent specialist source-control planning, especially with sepsis, hypotension, altered mentation, organ dysfunction or persistent obstruction. Antibiotics and resuscitation are essential but cannot drain an infected biliary system. The complete Charcot triad is not required. Ultrasound and other imaging help define obstruction, while ERCP or another drainage route is selected by the treating specialist and local capability.
Should tuberculosis treatment be started empirically for unexplained jaundice in India?
No. Tuberculosis can involve the liver, lymph nodes or biliary system, but unexplained jaundice also represents stones, viral or drug injury, autoimmune disease and cancer. Empirical antituberculous therapy may delay the correct diagnosis and can itself cause serious liver injury. Obtain appropriate imaging and microbiological or tissue evidence where feasible, and coordinate confirmed or strongly supported disease with TB and hepatology expertise.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic